FDA Issues Final Debarment Order Against Individual for Felony Drug Importation Conviction
Last updated 2026-06-17 · Source: FDA
Primary source: FDA: FDA Issues Final Debarment Order Against Individual for Felony Drug Importation Conviction
The Food and Drug Administration (FDA) has issued a final order debarring Andrew Jonathan Morgan for a period of 5 years from importing or offering for import any drug into the United States. This action stems from Mr. Morgan's felony conviction under federal law for conduct relating to the importation of a drug or controlled substance. Mr. Morgan waived his right to a hearing by not responding to the proposed debarment notice.
What this means for your practice
This FDA debarment order underscores the agency's vigilance in regulating the pharmaceutical supply chain and enforcing federal drug laws. For telehealth brands, medspas, dental practices, chiropractic offices, and other healthcare businesses, this action serves as a critical reminder of the importance of robust due diligence in sourcing all medical products, including drugs and controlled substances. Practices must ensure that any entities or individuals involved in their supply chain are not subject to FDA debarment or other enforcement actions, as this could lead to serious compliance risks, supply disruptions, and legal liabilities. Verifying the legitimacy and regulatory standing of all suppliers is paramount to maintaining patient safety and operational integrity. Ignorance of a supplier's debarred status is not a defense and can result in significant penalties for healthcare providers who knowingly or unknowingly procure products from such sources.
Rockville, MD – The U.S. Food and Drug Administration (FDA) has announced a final debarment order against Andrew Jonathan Morgan, prohibiting him from importing or offering for import any drug into the United States for a period of 5 years. This enforcement action, effective June 17, 2026, is a direct consequence of Mr. Morgan's conviction for a federal felony related to the importation of drugs or controlled substances.
Basis for the Debarment Order
The FDA's decision to debar Mr. Morgan is based on its findings under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, section 306(b)(1)(D) of the FD&C Act permits the debarment of an individual from importing or offering for import any drug into the United States if the FDA determines, as required by section 306(b)(3)(C) of the FD&C Act, that the individual was convicted of a felony under federal law.
In this case, the factual basis supporting Mr. Morgan's conviction involved conduct directly related to the importation into the United States of a drug or controlled substance. The FDA initiated the debarment process after establishing this felony conviction.
The Debarment Process and Waiver of Hearing
Before issuing the final order, the FDA provided Mr. Morgan with notice of the proposed debarment. This notice included an opportunity for him to request a hearing to present arguments as to why he should not be debarred. This procedural step ensures due process for individuals facing such regulatory actions.
However, as of April 29, 2026, which was 30 days after Mr. Morgan received the notice, he had not responded to the FDA. His failure to respond and request a hearing is legally considered a waiver of his right to a hearing concerning this matter. Consequently, the FDA proceeded with the final debarment order without further delay.
Scope and Duration of Debarment
The final order debarrs Mr. Morgan for a period of 5 years. During this time, he is explicitly prohibited from importing or offering for import any drug into the United States. This restriction is comprehensive, applying to any drug regardless of its classification or intended use.
Potential for Termination of Debarment
While the debarment is set for a 5-year term, the FD&C Act provides a mechanism for individuals to seek an early termination of their debarment. Under section 306(d)(1) of the FD&C Act (21 U.S.C. 335a(d)(1)), Mr. Morgan may submit an application for termination of debarment at any time.
Applications for termination can be submitted electronically via the Federal eRulemaking Portal at regulations.gov, following the instructions provided for submitting comments. Alternatively, written/paper submissions can be mailed or hand-delivered to the Dockets Management Staff at the FDA. The FDA emphasizes the importance of carefully managing confidential information within any submission, particularly for electronic filings where all information, including personal contact details, will be made public unless specifically marked and submitted as confidential via specific written procedures.
Regulatory Implications for Healthcare Businesses
This debarment serves as a significant regulatory signal, highlighting the FDA's ongoing efforts to safeguard the integrity of the U.S. drug supply chain. Healthcare businesses, including telehealth providers, medspas, dental practices, and chiropractic offices, are inherently reliant on a compliant and secure supply of drugs and medical devices.
The FDA's rigorous enforcement of debarment provisions means that businesses must exercise extreme caution and conduct thorough due diligence when selecting and vetting suppliers, distributors, and any third parties involved in their drug procurement processes. Operating with debarred individuals or entities, even unknowingly, can expose practices to substantial legal and regulatory risks. Providers should verify the non-debarred status of their partners to ensure compliance with federal law and to protect patient safety from potentially illicit or substandard imported products.
Source
Key Facts
| Detail | Value | |---|---| | Action | Final Debarment Order | | Debarred Individual | Andrew Jonathan Morgan | | Debarment Period | 5 years | | Effective Date | June 17, 2026 | | Basis for Debarment | Felony conviction under federal law for conduct related to drug/controlled substance importation | | Prohibited Activity | Importing or offering for import any drug into the United States |
Frequently Asked Questions
Why was Andrew Jonathan Morgan debarred by the FDA?
He was debarred because he was convicted of a felony under federal law, and the conduct supporting his conviction related to the importation into the United States of a drug or controlled substance.
For how long is Mr. Morgan debarred?
Andrew Jonathan Morgan is debarred for a period of 5 years.
What activities is Mr. Morgan prohibited from doing under this debarment?
He is prohibited from importing or offering for import any drug into the United States.
When did this debarment order become effective?
This debarment order became applicable on June 17, 2026.
Can Mr. Morgan appeal or seek termination of his debarment?
Yes, Mr. Morgan can submit an application for termination of debarment under section 306(d)(1) of the FD&C Act at any time.
Source: FDA — Notice: Andrew Jonathan Morgan: Final Debarment Order · 2026-06-17